Hachisuga, K.; Kawakami, M.; Tomonobe, H.; Maenohara, S.; Kodama, K.; Yagi, H.; Yasunaga, M.; Onoyama, I.; Asanoma, K.; Yahata, H.;
et al. Low-Grade Endometrial Cancer with Abnormal p53 Expression as a Separate Clinical Entity: Insights from RNA Sequencing and Immunohistochemistry. Diagnostics 2025, 15, 671.
https://doi.org/10.3390/diagnostics15060671
AMA Style
Hachisuga K, Kawakami M, Tomonobe H, Maenohara S, Kodama K, Yagi H, Yasunaga M, Onoyama I, Asanoma K, Yahata H,
et al. Low-Grade Endometrial Cancer with Abnormal p53 Expression as a Separate Clinical Entity: Insights from RNA Sequencing and Immunohistochemistry. Diagnostics. 2025; 15(6):671.
https://doi.org/10.3390/diagnostics15060671
Chicago/Turabian Style
Hachisuga, Kazuhisa, Minoru Kawakami, Hiroshi Tomonobe, Shoji Maenohara, Keisuke Kodama, Hiroshi Yagi, Masafumi Yasunaga, Ichiro Onoyama, Kazuo Asanoma, Hideaki Yahata,
and et al. 2025. "Low-Grade Endometrial Cancer with Abnormal p53 Expression as a Separate Clinical Entity: Insights from RNA Sequencing and Immunohistochemistry" Diagnostics 15, no. 6: 671.
https://doi.org/10.3390/diagnostics15060671
APA Style
Hachisuga, K., Kawakami, M., Tomonobe, H., Maenohara, S., Kodama, K., Yagi, H., Yasunaga, M., Onoyama, I., Asanoma, K., Yahata, H., Oda, Y., & Kato, K.
(2025). Low-Grade Endometrial Cancer with Abnormal p53 Expression as a Separate Clinical Entity: Insights from RNA Sequencing and Immunohistochemistry. Diagnostics, 15(6), 671.
https://doi.org/10.3390/diagnostics15060671
